The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
VYCO · Healthcare · Narrow moat
On the watchlist
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | SIGA | MSA | VYCO | LNTH |
|---|---|---|---|---|
| Moat Score (0–100) | 73 | 74 (highest) | 74 (highest) | 73 |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 15 | 90 (highest) | 70 | 75 |
| Pricing power | 91 | 77 | 100 (highest) | 72 |
| Returns on capital | 96 (highest) | 60 | — | 90 |
| Balance-sheet safety | 100 (highest) | 66 | 100 (highest) | 82 |
| Capital allocation | 63 | 74 (highest) | 24 | 46 |
| 66% below value if growth stopped today (largest discount to value if growth stopped today) | 232% above value if growth stopped today | No price data | 161% above value if growth stopped today | |
| Market cap | $223M | $6.8B | $2.3M | $6.8B |
| Moat tier | Narrow moat | Narrow moat | Narrow moat | Narrow moat |
| Filing date | FY2025 | FY2025 | FY2025 | FY2025 |